Bhabatosh Banik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bhabatosh Banik has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Shanta Dhar
University of Miami Miller School of Medicine
3 shared publications - Bapurao Surnar
NanoTherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
2 shared publications Nursaima Sultana Parbin
Department of Chemistry Cotton University Pan bazar Guwahati Assam 781001 India
2 shared publications- Akash Ashokan
NanoTherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
1 shared publication - Akhil R. Chakravarty
Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore 560012, India
1 shared publication - Akhtar Hussain
Department of Chemistry, Handique Girls’ College, Guwahati 781001, Assam, India
1 shared publication
Latest Publications
- 7 November 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (42)
Self‐Assembled CuPer 25 ‐BSA‐NPs Having Self‐Supply of H 2 O 2 as Peroxidase Mimetic Nanozyme for Detection of Cysteine in Biofluids
Biomarkers have emerged to serve as an important tool for determination of parameters of clinical relevance that enables diagnosis, screening, characterization, and monitoring of progress of diseases in a fast, easy, efficient, and selective manner. Early diagnosis, meticulous characterization, and ability to follow disease prognosis is of particular importance in the context of cancer. Cysteine has recently attracted considerable importance as a possible cancer biomarker as its altered levels are often associated with development of the disease. Among the various methods for cysteine detection, colorimetric method is a preferred one as it is fast, easy, provides measurable outputs, and often are visible to naked eyes. POD‐like activities of transition metal‐based nanomaterials have been used for cysteine detection but research for more efficient materials are ongoing. Herein, we report BSA nanoparticle incorporated with copper peroxide (CuPer‐BSA‐NPs) that are capable of generating reactive oxygen species (ROS) induced by mildly acidic pH of ∼5.5. Acidic conditions trigger the generation of Cu 2+ and H 2 O 2 and initiate a Fenton‐type reaction to generate hydroxyl radicals. Suitable substrate such as 3,3′,5,5′‐tetramethylbenzidine (TMB) gets oxidized by the generated ROS in presence of Cu 2+ in a POD‐like catalytic process. Cysteine, by virtue of reducing nature of the thiol groups, interacts with the TMB oxidation process, thereby enabling detection of cysteine. We have evaluated POD activity of a copper peroxide incorporated BSA nanoparticle formulation for the detection of cysteine in biological fluids. The novel composition, pH‐dependent self‐supply of H 2 O 2 , faster rates of POD‐like activity and selectivity toward cysteine detection make CuPer‐BSA‐NPs a suitable agent for cysteine detection in biofluids.
- 7 November 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (42)
Self‐Assembled CuPer 25 ‐BSA‐NPs Having Self‐Supply of H 2 O 2 as Peroxidase Mimetic Nanozyme for Detection of Cysteine in Biofluids
Biomarkers have emerged to serve as an important tool for determination of parameters of clinical relevance that enables diagnosis, screening, characterization, and monitoring of progress of diseases in a fast, easy, efficient, and selective manner. Early diagnosis, meticulous characterization, and ability to follow disease prognosis is of particular importance in the context of cancer. Cysteine has recently attracted considerable importance as a possible cancer biomarker as its altered levels are often associated with development of the disease. Among the various methods for cysteine detection, colorimetric method is a preferred one as it is fast, easy, provides measurable outputs, and often are visible to naked eyes. POD‐like activities of transition metal‐based nanomaterials have been used for cysteine detection but research for more efficient materials are ongoing. Herein, we report BSA nanoparticle incorporated with copper peroxide (CuPer‐BSA‐NPs) that are capable of generating reactive oxygen species (ROS) induced by mildly acidic pH of ∼5.5. Acidic conditions trigger the generation of Cu 2+ and H 2 O 2 and initiate a Fenton‐type reaction to generate hydroxyl radicals. Suitable substrate such as 3,3′,5,5′‐tetramethylbenzidine (TMB) gets oxidized by the generated ROS in presence of Cu 2+ in a POD‐like catalytic process. Cysteine, by virtue of reducing nature of the thiol groups, interacts with the TMB oxidation process, thereby enabling detection of cysteine. We have evaluated POD activity of a copper peroxide incorporated BSA nanoparticle formulation for the detection of cysteine in biological fluids. The novel composition, pH‐dependent self‐supply of H 2 O 2 , faster rates of POD‐like activity and selectivity toward cysteine detection make CuPer‐BSA‐NPs a suitable agent for cysteine detection in biofluids.
- 11 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (30) , 5605-5608
Copper peroxide incorporated BSA-NPs: a pH-responsive, self-supplying source of reactive oxygen species for cancer cell destruction via polarization of macrophages to the M1 phenotype
Herein, we synthesized CuPer-BSA-NPs that release Cu2+ and H2O2 at acidic pH, activating a Fenton-type reaction to produce ˙OH radicals, which polarize RAW 264.7 macrophages to the M1 phenotype for enhanced anti-cancer effects against HeLa cells.
- 11 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (30) , 5605-5608
Copper peroxide incorporated BSA-NPs: a pH-responsive, self-supplying source of reactive oxygen species for cancer cell destruction via polarization of macrophages to the M1 phenotype
Herein, we synthesized CuPer-BSA-NPs that release Cu2+ and H2O2 at acidic pH, activating a Fenton-type reaction to produce ˙OH radicals, which polarize RAW 264.7 macrophages to the M1 phenotype for enhanced anti-cancer effects against HeLa cells.
- 13 January 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (12) , 3575-3585
Platin-C containing nanoparticles: a recipe for the delivery of curcumin–cisplatin combination chemotherapeutics to mitochondria
We report the synthesis of a curcumin–cisplatin combination chemotherapeutic agent, Platin-C, suitably packaged in a mitochondrion-targeted nanovehicle for enhanced anticancer efficacy and diminished chemotherapy-associated inflammation.
- 13 January 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (12) , 3575-3585
Platin-C containing nanoparticles: a recipe for the delivery of curcumin–cisplatin combination chemotherapeutics to mitochondria
We report the synthesis of a curcumin–cisplatin combination chemotherapeutic agent, Platin-C, suitably packaged in a mitochondrion-targeted nanovehicle for enhanced anticancer efficacy and diminished chemotherapy-associated inflammation.
- Open Access
- 15 January 2021
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 33 (2) , 453-458
Synthesis, Characterization and Antimicrobial Properties of [Cu2(μ-O2CC9H19)4(4-CNpy)2]
Reports on the isolation and crystallographic characterization of metal carboxylates having long alkyl chains are relatively rare. Herein, a dinuclear copper(II) tetracaprate (i.e. tetradecanoate) complex, [Cu2(μ-O2CC9H19)4(4-CNpy)2] (I), where 4-CNpy = 4-cyanopyridine is reported. The complex has been synthesized by a facile method and characterized by various physico-chemical techniques such as IR and UV-vis spectroscopy, magnetic susceptibility measurement and single crystal X-ray diffraction. The structure is dimeric with the familiar paddle-wheel geometry, which was originally observed in the structure of copper(II) acetate monohydrate. In the dimeric structure, both copper(II) centres display distorted square pyramidal geometry. The substituted pyridine ligands occupy the apical positions through the pyridyl nitrogen atoms. Complex I has been tested for antimicrobial behaviour against a few bacterial strains. Owing to the redox-active nature of copper, complex I shows considerable promise as an antimicrobial agent.
- 15 January 2021
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 33 (2) , 453-458
Open AccessSynthesis, Characterization and Antimicrobial Properties of [Cu2(μ-O2CC9H19)4(4-CNpy)2]
Reports on the isolation and crystallographic characterization of metal carboxylates having long alkyl chains are relatively rare. Herein, a dinuclear copper(II) tetracaprate (i.e. tetradecanoate) complex, [Cu2(μ-O2CC9H19)4(4-CNpy)2] (I), where 4-CNpy = 4-cyanopyridine is reported. The complex has been synthesized by a facile method and characterized by various physico-chemical techniques such as IR and UV-vis spectroscopy, magnetic susceptibility measurement and single crystal X-ray diffraction. The structure is dimeric with the familiar paddle-wheel geometry, which was originally observed in the structure of copper(II) acetate monohydrate. In the dimeric structure, both copper(II) centres display distorted square pyramidal geometry. The substituted pyridine ligands occupy the apical positions through the pyridyl nitrogen atoms. Complex I has been tested for antimicrobial behaviour against a few bacterial strains. Owing to the redox-active nature of copper, complex I shows considerable promise as an antimicrobial agent.
- 30 December 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (6) , 6852-6862
Dual-Targeted Synthetic Nanoparticles for Cardiovascular Diseases
AAtherosclerosis is one of the world’s most aggressive diseases, claiming over 17.5 million lives per year. This disease is usually caused by high amounts of lipoproteins circulating in the blood stream, which leads to plaque formation. Ultimately these plaques can undergo thrombosis and lead to major heart damage. A major contributor to these vulnerable plaques is macrophage apoptosis. Development of nanovehicles that carry contrast and therapeutic agents to the mitochondria within these macrophages is attractive for diagnosis and treatment of atherosclerosis. Here, we report the design and synthesis of a dual targeted synthetic nanoparticle to perform double duty of diagnosis and therapy in atherosclerosis treatment regime. A library of dual targeted nanoparticles (NPs) with an encapsulated iron oxide nanoparticle, mito-magneto with magnetic resonance imaging (MRI) contrast enhancement capabilities were elucidated. Relaxivity measurements revealed that there is substantial enhancement in transverse relaxivities upon encapsulation of mito-magneto inside the dual-targeted NPs highlighting MRI contrast enhancing abilities of these NPs. Successful in vivo imaging documenting distribution of mito-magneto encapsulated dual targeted NPs in the heart and aorta in mice ensured the diagnostic potential. The presence of mannose receptor targeting ligands and optimization of the NP composition facilitated its ability to perform therapeutic duty by targeting the macrophages at the plaque. These dual-targeted NPs with encapsulated mito-magneto were able to show therapeutic potential and did not trigger any toxic immunogenic response.
- 30 December 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (6) , 6852-6862
Dual-Targeted Synthetic Nanoparticles for Cardiovascular Diseases
AAtherosclerosis is one of the world’s most aggressive diseases, claiming over 17.5 million lives per year. This disease is usually caused by high amounts of lipoproteins circulating in the blood stream, which leads to plaque formation. Ultimately these plaques can undergo thrombosis and lead to major heart damage. A major contributor to these vulnerable plaques is macrophage apoptosis. Development of nanovehicles that carry contrast and therapeutic agents to the mitochondria within these macrophages is attractive for diagnosis and treatment of atherosclerosis. Here, we report the design and synthesis of a dual targeted synthetic nanoparticle to perform double duty of diagnosis and therapy in atherosclerosis treatment regime. A library of dual targeted nanoparticles (NPs) with an encapsulated iron oxide nanoparticle, mito-magneto with magnetic resonance imaging (MRI) contrast enhancement capabilities were elucidated. Relaxivity measurements revealed that there is substantial enhancement in transverse relaxivities upon encapsulation of mito-magneto inside the dual-targeted NPs highlighting MRI contrast enhancing abilities of these NPs. Successful in vivo imaging documenting distribution of mito-magneto encapsulated dual targeted NPs in the heart and aorta in mice ensured the diagnostic potential. The presence of mannose receptor targeting ligands and optimization of the NP composition facilitated its ability to perform therapeutic duty by targeting the macrophages at the plaque. These dual-targeted NPs with encapsulated mito-magneto were able to show therapeutic potential and did not trigger any toxic immunogenic response.
- 10 December 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (52) , 201816429-E12342
Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection
The success of nanoparticle-mediated delivery of antioxidant and antiinflammatory-based neuroprotectants to the brain to improve neuronal functions in neurodegenerative diseases has demonstrated lesser impact instead of achieving its full potential. We hypothesized that these failures were due to a combination of parameters, such as: (i) unavailability of a delivery vehicle, which can reproducibly and efficiently transport through the brain capillary endothelium; (ii) inefficient uptake of therapeutic nanoparticles in the neuronal cell population; and (iii) limited ability of a single nanoparticle to cross the two most-impermeable biological barriers, the blood–brain barrier and mitochondrial double membrane, so that a nanoparticle can travel through the brain endothelial barrier to the mitochondria of target cells where oxidative damage is localized. Herein, we demonstrate optimization of a biodegradable nanoparticle for efficient brain accumulation and protection of astrocytes from oxidative damage and mitochondrial dysfunctions to enhance the neuroprotection ability of astrocytes toward neurons using neurodegeneration characteristics in SOD1G93A rats. This biodegradable nanomedicine platform with the ability to accumulate in the brain has the potential to bring beneficial effects in neurodegenerative diseases by modulating the stars, astrocytes in the brain, to enhance their neuroprotective actions. Significance Neurodegenerative disorders touch many lives in the form of various diseases. Therapeutic interventions of such disorders are limited due to the difficulty in reaching the neurons by crossing the impermeable blood–brain barrier. Scientists have created nanoscopic particles to take therapeutics to the brain; however, the results have not been very encouraging due to the inefficient ability of the nanoplatforms in crossing the blood–brain barrier and to accumulate in the target neuron cells effectively as uptake of nanomaterials by neurons is difficult to achieve. We provide a biodegradable nanoparticle platform with efficient brain astrocyte accumulation properties to provide an alternative approach to tackle neurodegenerative processes by improving and enhancing astrocyte’s natural protection ability toward neurons for neuromedicine.
- 10 December 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (52) , 201816429-E12342
Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection
The success of nanoparticle-mediated delivery of antioxidant and antiinflammatory-based neuroprotectants to the brain to improve neuronal functions in neurodegenerative diseases has demonstrated lesser impact instead of achieving its full potential. We hypothesized that these failures were due to a combination of parameters, such as: (i) unavailability of a delivery vehicle, which can reproducibly and efficiently transport through the brain capillary endothelium; (ii) inefficient uptake of therapeutic nanoparticles in the neuronal cell population; and (iii) limited ability of a single nanoparticle to cross the two most-impermeable biological barriers, the blood–brain barrier and mitochondrial double membrane, so that a nanoparticle can travel through the brain endothelial barrier to the mitochondria of target cells where oxidative damage is localized. Herein, we demonstrate optimization of a biodegradable nanoparticle for efficient brain accumulation and protection of astrocytes from oxidative damage and mitochondrial dysfunctions to enhance the neuroprotection ability of astrocytes toward neurons using neurodegeneration characteristics in SOD1G93A rats. This biodegradable nanomedicine platform with the ability to accumulate in the brain has the potential to bring beneficial effects in neurodegenerative diseases by modulating the stars, astrocytes in the brain, to enhance their neuroprotective actions. Significance Neurodegenerative disorders touch many lives in the form of various diseases. Therapeutic interventions of such disorders are limited due to the difficulty in reaching the neurons by crossing the impermeable blood–brain barrier. Scientists have created nanoscopic particles to take therapeutics to the brain; however, the results have not been very encouraging due to the inefficient ability of the nanoplatforms in crossing the blood–brain barrier and to accumulate in the target neuron cells effectively as uptake of nanomaterials by neurons is difficult to achieve. We provide a biodegradable nanoparticle platform with efficient brain astrocyte accumulation properties to provide an alternative approach to tackle neurodegenerative processes by improving and enhancing astrocyte’s natural protection ability toward neurons for neuromedicine.
- 16 October 2013
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 43 (3) , 1321-1331
Carbohydrate-appended photocytotoxic (imidazophenanthroline)-oxovanadium(iv) complexes for cellular targeting and imaging
Oxovanadium(IV) complexes [VO(aip)(L)](ClO4)2 (L = phtpy, 1; stpy, 2) and [VO(pyip)(L)](ClO4)2 (L = phtpy, 3; stpy, 4), where aip is 2-(9-anthryl)-1H-imidazo[4,5-f][1,10]phenanthroline, pyip is [2-(1-pyrenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, phtpy is (4′-phenyl)-2,2′:6′,2′′-terpyridine and stpy is (2,2′:6′,2′′-terpyridin-4′-oxy)ethyl-β-D-glucopyranoside, were prepared, characterized and their DNA binding and photocleavage activity, cellular uptake and photocytotoxicity in visible light were studied. The complexes are avid binders to calf thymus DNA (Kb ∼105 mol−1). They efficiently cleave pUC19 DNA in red light of 705 nm via the formation of HO˙ species. The glucose appended complexes 2 and 4 showed higher photocytotoxicity in HeLa and Hep G2 cells over the normal HEK 293T cells. No such preference was observed for the phtpy complexes 1 and 3. No significant difference in IC50 values was observed for the HEK 293T cells. Cell cycle analysis showed that the glucose appended complexes 2 and 4 are more photocytotoxic in cancer cells than in normal cells. Fluorescence microscopy was done to study the cellular localization of complex 4 having a pendant pyrenyl group.
- 16 October 2013
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 43 (3) , 1321-1331
Carbohydrate-appended photocytotoxic (imidazophenanthroline)-oxovanadium(iv) complexes for cellular targeting and imaging
Oxovanadium(IV) complexes [VO(aip)(L)](ClO4)2 (L = phtpy, 1; stpy, 2) and [VO(pyip)(L)](ClO4)2 (L = phtpy, 3; stpy, 4), where aip is 2-(9-anthryl)-1H-imidazo[4,5-f][1,10]phenanthroline, pyip is [2-(1-pyrenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, phtpy is (4′-phenyl)-2,2′:6′,2′′-terpyridine and stpy is (2,2′:6′,2′′-terpyridin-4′-oxy)ethyl-β-D-glucopyranoside, were prepared, characterized and their DNA binding and photocleavage activity, cellular uptake and photocytotoxicity in visible light were studied. The complexes are avid binders to calf thymus DNA (Kb ∼105 mol−1). They efficiently cleave pUC19 DNA in red light of 705 nm via the formation of HO˙ species. The glucose appended complexes 2 and 4 showed higher photocytotoxicity in HeLa and Hep G2 cells over the normal HEK 293T cells. No such preference was observed for the phtpy complexes 1 and 3. No significant difference in IC50 values was observed for the HEK 293T cells. Cell cycle analysis showed that the glucose appended complexes 2 and 4 are more photocytotoxic in cancer cells than in normal cells. Fluorescence microscopy was done to study the cellular localization of complex 4 having a pendant pyrenyl group.